Natural Language Processing-Based Feedback to Improve Communication and Decision Making in Men With Prostate Cancer

What is the Purpose of this Study?

The purpose of the study is to assess the impact of an artificial intelligence (AI)-based risk communication feedback system to improve patient decision making and quality of physician risk communication during prostate cancer consultations. The study focuses on people who have been newly diagnosed with early-stage prostate cancer. The study will audio record the patient’s treatment consultation and use AI to extract key information and create patient-specific summaries to help patients make informed health decisions. The study will also provide feedback to physicians on their quality of risk communication to help them improve quality of counseling.


Eligibility


Where can I participate?

Beverly

More about this Clinical Trial

What is the full name of this clinical trial?

Natural Language Processing-Based Feedback to Improve Physician Risk Communication and Informed Shared Decision Making in Men with Clinically Localized Prostate Cancer

Study Details
Disease Type/Condition

Other

Principal Investigator

Daskivich, Timothy

Age Group

Adult

Phase

N/A

IRB Number

STUDY00003620

ClinicalTrials.gov ID

NCT06856694

Key Eligibility
ClinicalTrials.gov

How do I learn more about this study?
Email
clinicaltrials@cshs.org
Study Detail
Disease Type/Condition

Other

Principal Investigator

Daskivich, Timothy

Age Group

Adult

Phase

N/A

IRB Number

STUDY00003620

ClinicalTrials.gov ID

NCT06856694

Key Eligibility
ClinicalTrials.gov

Contact
Email
clinicaltrials@cshs.org